missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Rekombinante Proteine
  4. 18057323

Novus Biologicals™ Recombinant Human p21/CIP1/CDKN1A His Protein

Artikelnummer. 18057323 Alle ansehen Bio Techne Produkte
Click to view available options
Menge:
100 μg
Packungsgröße:
100 Mikrogramm
Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen

Artikelnummer. 18057323

Marke: Novus Biologicals™ NBP222976100UG

om dit product te kopen Registreer vandaag om een webaccount aan te maken

Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen

Beschreibung

Highly purified. Generating reliable and reproducible results. Applications: SDS-Page

A denatured recombinant protein with a N-Terminal His-tag and corresponding to the amino acids 1-164 of Human p21/CIP1/CDKN1A The Recombinant Human p21/CIP1/CDKN1A Protein is derived from E. coli. The Recombinant Human p21/CIP1/CDKN1A Protein has been validated for the following applications: SDS-Page.
TRUSTED_SUSTAINABILITY

Spezifikation

Konzentration 0.5mg/mL
Zur Verwendung mit (Anwendung) SDS-PAGE
Zusammensetzung 20mM Tris-HCl buffer (pH 8.0) containing 2M urea, 10% glycerol, 0.1M NaCl
Gen-ID (Entrez) 1026
Molekulargewicht 20.2 kDa
Menge 100 μg
Quelle E. coli
Lagerungsbedingungen Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Gensymbol CDKN1A
Spezies Human
Reinheits- oder Qualitätsgrad >85%, by SDS-PAGE
Mehr anzeigen Weniger anzeigen
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.